Reding Andrew P. 4
4 · Predictive Oncology Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
Reding Andrew P.
Director
Transactions
- Award
Stock Option (right to buy)
2019-12-31+5,747→ 5,747 totalExercise: $2.61From: 2019-12-31Exp: 2029-12-31→ Common Stock (5,747 underlying)
Holdings
- 6
Common Stock, $.01 par value
Footnotes (1)
- [F1]Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on October 29, 2019.